Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants

Journal of Child Neurology

Volumn 23, Issue 4, 2008, Pages 421-424

  Needelman, Howard ^a   Evans, Martha ^c,d   Roberts, Holly ^a   Sweney, Matthew ^b   Bodensteiner, J B ^e  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^e ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Developmental outcome; Dexamethasone; Premature infant

Indexed keywords

DEXAMETHASONE;

ARTICLE; CHILD DEVELOPMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEVELOPMENTAL DISORDER; DRUG SAFETY; EARLY CHILDHOOD INTERVENTION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HIGH RISK INFANT; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NEWBORN INTENSIVE CARE; OUTCOMES RESEARCH; PERINATAL DRUG EXPOSURE; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM;

ANTI-INFLAMMATORY AGENTS; DEVELOPMENTAL DISABILITIES; DEXAMETHASONE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREMATURE BIRTH; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 41549146265     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807309232     Document Type: Article

References (12)

1. Lemons JA, Bauer CR, Oh W., et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics. 2001;107:1E.
2. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350:1304-1313.
3. American Academy of Pediatrics. Postnatal corticosteroids to treat or prevent chronic lung disease in premature infants. Pediatrics. 2002;109:330-338.
4. American Academy of Pediatrics. AAP publications retired or reaffirmed, May 2004. Pediatrics. 2006;117:1846-1847.
5. Vohr BR, Msall ME Follow-up of high-risk infants. In: Vergora ER, Bibsby R, eds. Developmental and Therapeutic Interventions in the NICU. Baltimore, MD: Brookes; 2004:267-292.
6. Gross SJ, Mettelman BD, Dye DD, et al. Impact of family structure and stability on academic outcome in preterm children at 10 years of age. J Pediatr. 2001;138:169-175.
7. Sattler JM Assessment of Children: Cognitive Applications. San Diego, CA: Sattler; 2001:169-170, 547-548.
8. Jobe AH Postnatal corticosteroids for preterm infants-do what we say, not what we do. N Engl J Med. 2004;350:1349-1351.
9. Rubin IL Prematurity and its consequences. In: Rubin IR and Crocker AC, eds. Medical Care for Children and Adults with Developmental Disabilities. Baltimore, MD: Brookes; 2006:217-232.
10. Halliday HL, Ehrenkranz RA, Doyle LW Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;1:CD00146.
11. Murphy BP, Inde TE, Huppi PS, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics. 2001;107:217-221.
12. Parikh NA, Lasky RE, Kennedy KA, et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics. 2007;119:265-272.